Life Sciences (Pharma MedTech) Consulting Services Mumbai, India
India has emerged as a global hub for contract research and manufacturing services (CRAMS) and related industries. Recent developments have seen renowned players expanding their global presence while strategically leveraging India’s extensive capabilities. Traditionally known for its strengths in chemical and related services, India is now building significant expertise across a diverse array of platforms.
In the area of life sciences, we have advised clients across the spectrum, from discovery to commercial manufacturing. Our consulting experience spans discovery sciences; biotech and chemicals, clinical development, formulation development and services and commercial manufacturing.
Pharmaceuticals & Biotechnology
The Indian pharmaceutical and biotechnology industry is experiencing significant growth, driven by factors such as government support, robust domestic demand, medical tourism, infrastructure development, a focus on R&D, and strong drug manufacturing capabilities. As one of the largest suppliers of low-cost drugs and vaccines globally, India attracts research-led major pharma companies looking to capitalise on the expanding domestic and international markets.
However, amidst rising competition, these companies face several challenges, including understanding industry dynamics for peak revenue estimates, navigating the patent environment, and addressing pricing and market access issues. Additionally, they must balance affordability with innovation, compete in global markets, and manage supply chain disruptions.
UC assists organisations in navigating business challenges by providing evidence-based, actionable insights. Clients engage UC for support with market access, peak revenue estimates, entry strategies, business plans, and pricing and reimbursement.
Key Engagements:
- Evaluated the market for a novel breast cancer molecule in India and Turkey.
- Analysed the Indian market for therapeutic neurotoxins.
- Assessed the Japanese and EU NDDS market for Parkinson’s.
- Developed a growth strategy for the diabetes care segment, integrating diagnostics, therapeutics, and nutrition for a leading MNC in India.
- Created an India entry strategy for a leading radiology services player in Europe.
- Formulated a strategy to grow the ophthalmic care segment for a major MNC in India.
- Assessed the impact of changes in pricing policy on the long-range plans of a leading MNC pharma in India.
- Validated growth prospects and conducted valuation of a Jordanian pharma player prior to divestment by a PE investor.
- Developed a partner screen to support the distribution of hormonal therapies for a specialty pharma company in the Middle East and Turkey.
Through these engagements, UC has demonstrated its expertise in helping clients achieve their strategic objectives and navigate complex market landscapes.
Segments
Drugs & Intermediates
Indigenous System of Medicine
Formulations
CRO
Drug Discovery & Development Services
CRAMS
Vaccines & Biological Products
Consumer Health Products
Products
Prescription Drugs
Novel Molecule
APIs
Dietary Supplements
Novel Drug Delivery System
Veterinary Drugs
Diversified Drugs & Intermediates
Organic Extracts
OTC
Alternative Medicine
What Clients Say
Medical Technology
India is one of the fastest-growing medical devices markets among emerging markets, with the MedTech sector expected to reach $50 billion by 2025, growing consistently at a CAGR of 15% over the last three years. The domestic industry primarily focuses on consumables, test kits, and lower-value equipment, but some domestic firms have expanded local manufacturing to produce cost-effective, medium-end medical devices. This growth can be attributed to several key drivers, including a growing middle class, increasing disposable income, a rise in medical tourism, and significant medical infrastructure development.
UC has developed and evolved market shaping strategies for cutting-edge technologies, working with numerous Medical Technology clients to assist them in India Entry Strategy and Go-To-Market Strategy. This includes both Medical Devices and Bio-Pharma Consulting. Additionally, UC caters to the needs of companies for Distribution and Channel Strategy, particularly focusing on value segment and mid-tier segment approaches. Implementing Strategy Execution, Program Management Office, and Strategic Cost Management is also a vital part of UC’s services.
Key Engagements:
- Assessed opportunities in the Indian diagnostics segment.
- Evaluated manufacturing relocation to India.
- Developed a market entry strategy for Value Intra Ocular Lens in India.
- Assisted hospitals in navigating budget and technology pressures related to MedTech equipment.
- Helped MedTech companies be strategic about product introductions to increase profitability.
UC combines strategic acumen with extensive industry insight to help clients enhance business performance and gain market share in the competitive MedTech landscape.
Segments
Therapeutic & Drug Delivery
Consumables & Disposables
Implants
Instruments & Equipment
Products
DNA Instrument
Hearing Aids
Pacemaker
Molecular Diagnostics
R & D Tools
Defibrillator
Sample Handling
Stents
Metals, Plates, Discs
Blood Culture
Valves
Basic Metabolic Panel
Deep Brain Stimulation
Baclofen
Knee Replacement
Spinal Cord Stimulator
Intraocular Lenses
NGS Equipment
The healthcare industry in India has advanced at a remarkable pace over the last decade, with significant contributions from private players in the sector. The industry is becoming more advanced and growing rapidly due to several key drivers such as Robotic Process Automation (RPA), policy support and incentives, insurance coverage, and medical infrastructure development.
UC combines strategic acumen with extensive industry insight to help clients enhance business performance and gain market share through our service offerings, including Strategy Formulation, Organisation Design, Operations Improvement, and Implementation. Given UC’s healthcare sector experience, healthcare companies and related service providers approach UC to assist with the creation and execution of growth strategies, as well as building successful entry and survival strategies amidst the intense competition in the Indian healthcare space.
UC leverages strategic expertise and extensive industry knowledge to support clients in solving their business challenges across various therapeutic areas, including Immunology, Endocrinology, Oncology, and Dermatology.
Key Engagements:
- Developed a growth strategy for differentiated formulations for a leading CRAMS player.
- Assessed partnership options with IVF centers in India for an overseas client.
- Conducted an opportunity assessment in ophthalmology pharmaceuticals.
- Examined cost optimisation opportunities in European operations for a leading Indian CRAMS player.
- Assessed the market for a novel breast cancer molecule in India and Turkey.
- Identified partners to outsource early-stage drug development for a global pharma major.
- Executed an organisation review for a large formulations player in India and the US.
Through these engagements, UC has demonstrated its ability to deliver strategic solutions that drive growth and efficiency for clients in the healthcare sector.
